Skip to main content

Table 3  Risk of ischemic stroke in subjects with migraine according to use of hormonal contraceptives

From: Hormonal contraceptives and risk of ischemic stroke in women with migraine: a consensus statement from the European Headache Federation (EHF) and the European Society of Contraception and Reproductive Health (ESC)

Study

Population

Comparison

Odds ratio (95% confidence interval)

Adjustment factors

Any migraine

    

 Collaborative Group, 1975 [33]

Women with stroke, hospital controls

Women with migraine and HC use vs non-migraineurs, non-HC users

4.6 (2.2–9.6)*

Age

 

Women with stroke, neighbor controls

Women with migraine and HC use vs non-migraineurs, non-HC users

4.6 (2.2–9.6)*

Age

 Lidegaard 1995 [36]

Women with ischemic stroke, controls

Smokers, HC users, and migraineurs vs non-smokers, non-HC users, and non-migraineurs

3.3 (P < 0.01)

HC, diabetes, arterial hypertension, other diseases

 Tzourio, 1995 [18]

Women with stroke, controls

Women with migraine and HC use vs non-migraineurs, non-HC users

13.9 (5.5–35.1)

Not reported

 Schwartz, 1998 [34]

Women with migraine

HC users vs non-HC users

2.1 (1.2–3.7)

Age, smoking, body mass index

 Chang, 1999 [11]

Women with stroke, controls

Women with migraine and HC use vs non-migraineurs, non-HC users

16.9 (2.7–106)

Hypertension, education, smoking, family history of migraine, alcohol use, social class

 

Women with stroke, controls

Women with migraine, smoke, and HC use vs non-migraineurs, non-smokers, and non-HC users

34.4 (3.3–361)

Not reported

 Milhaud, 2001 [38]

Women with ischemic stroke

Women with migraine and HC use vs non-migraineurs, non-HC users

2.7 (1.2–6.0)

Not reported

Migraine with aura

    

 MacClellan, 2007 [17]

Women with migraine with aura

Smokers and HC users vs non-smokers and non-HC users

7.0 (1.4–22.8)

Age, race, geographic region, study period

 

Women with stroke, controls

Women with migraine with aura, smokers, and HC users, vs non-migraineurs, non-smokers, and non-HC users

10.0 (1.4–73.7)

Age, race, geographic region, study period

 Champaloux, 2017 [10]

Women with stroke, controls

Women with migraine with aura and HC users vs non-migraineurs and HC users

6.1 (3.1–12.1)

Hypertension, diabetes, obesity, smoking, ischemic heart disease, valvular heart disease

 

Women with stroke, controls

Women with migraine with aura and non-HC users vs non-migraineurs and non-HC users

2.7 (1.9–3.7)

Hypertension, diabetes, obesity, smoking, ischemic heart disease, valvular heart disease

Migraine without aura

    

 Champaloux, 2017 [10]

Women with stroke, controls

Women with migraine without aura and HC users vs non-migraineurs and HC users

1.8 (1.1–2.9)

Hypertension, diabetes, obesity, smoking, ischemic heart disease, valvular heart disease

 

Women with stroke, controls

Women with migraine without aura and non-HC users vs non-migraineurs and non-HC users

2.2 (1.9–2.7)

Hypertension, diabetes, obesity, smoking, ischemic heart disease, valvular heart disease

  1. *Relative risk; HC indicates hormonal contraceptives